research associate II
Katelyn Busse is a Research Associate II at Juvena Therapeutics, where she focuses on screening and validation of drug candidates using in vitro high throughput screening. Skilled in both muscle biology and drug discovery, she is working on perfecting aspects of our high throughput screening pipeline, to help discover new drug candidates that rejuvenate aged stem cells. Katelyn joined Juvena Therapeutics in April of 2019.
Katelyn started her biotech R&D career during her undergraduate studies at Rochester Institute of Technology. While earning her Bachelors of Science in Biomedical Engineering, she completed full-time co-ops at Janssen Pharmaceuticals, Wake Forest Institute for Regenerative Medicine, and the NanoBio Device Lab at Rochester Institute of Technology. After graduation, she moved to San Diego to begin working with Genea Biocells where she spent 3 years improving the skeletal muscle differentiation media suite and developing secondary assays for use in their disease pipelines based on human embryonic stem cell derived skeletal muscle. Katelyn and her team earned the FDA’s Orphan Drug Designation for a lead compound in the treatment of Facioscapulohumeral Muscular Dystrophy (FSHD).
For fun, Katelyn likes to ride her bike and read on her kindle. Whenever possible, she enjoys a great cup of coffee or discovering new wines.